JACC Specialty Journals

JACC: Advances - Canadian Cost-Effectiveness of Coronary Artery Calcium Screening Based on the Multi-Ethnic Study of Atherosclerosis 24.04.2024 3:03 ↓

Commentary by Dr. Candice Silversides

JACC: Advances - Individualized Dose-Response to Statins Associated With Cardiovascular Disease Outcomes 24.04.2024 2:56 ↓

Commentary by Dr. Candice Silversides

JACC: Advances - Muesli Intake May Protect Against Coronary Artery Disease: Mendelian Randomization on 13 Dietary Traits 24.04.2024 2:40 ↓

Commentary by Dr. Candice Silversides

JACC: Advances - Initiation of Statins for Primary Prevention in Heart Failure With Preserved Ejection Fraction 24.04.2024 3:03 ↓

Commentary by Dr. Candice Silversides

JACC: Advances - Sex and Age Characteristics in Acute or Chronic Myocarditis: A Descriptive, Multicenter Cohort Study 24.04.2024 2:46 ↓

Commentary by Dr. Candice Silversides

JACC: Advances - Prediction of the Individual Aortic Stenosis Progression Rate and its Association With Clinical Outcomes 24.04.2024 2:35 ↓

Commentary by Dr. Candice Silversides

JACC: Clinical Electrophysiology - Clinical Significance of Supraventricular Tachycardia during Pregnancy in Healthy Women 24.04.2024 5:14 ↓

Commentary by Ratika Parkash

JACC: CardioOncology Pulse - Clinical Risk Mitigation, Pathophysiology, and Genetics of Anthracycline-Associated Cardiomyopathy 23.04.2024 13:20 ↓

Aarti Asnani, MD discusses anthracyline-induced cardiomyopathy, including risk mitigation strategies, underlying pathogenesis, genetic variants associated with increased risk of this adverse event, and gaps in our understanding. Moderated by Sarah Waliany, MD, MS.

JACC: CardioOncology Pulse - Health Incentives, Behavioral Economics and Cardio-Oncology 23.04.2024 26:44 ↓

Alexander Fanaroff, MD, MHS discusses how behavioral economic principles can be used to incentivize healthy behaviors in cardio-oncology. Moderated by Nicholas Wilcox, MD, MHS.

JACC: Basic to Translational Science - Introducing The 2024 Technology and Heart Failure Therapeutics Shark Tank Edition of JACC: Basic to Translational Science 22.04.2024 11:47 ↓

Commentary by Dr. Douglas Mann and Dr. Daniel Burkhoff

JACC Edge Podcast - ACC.24 Recap 18.04.2024 13:58 ↓

Commentary by Drs. Pratik Doshi, Nare Torosyan, current Cardiology Fellow at the Keck School of Medicine of USC, and Janet Wei, the newly minted ACC Southern California Governor and Associate Program Director of Cardiology fellowship at Cedars Sinai Medical Center, sharing their insights from ACC.24 in Atlanta.

JACC: Asia - Benchmarking System Monitoring on Quality Improvement in Percutaneous Coronary Intervention: A Nationwide Registry in Japan 17.04.2024 2:41 ↓

Commentary by Dr Jiang Jun

JACC: Asia - Pre-Existing Left Bundle Branch Block and Clinical Outcomes After Transcatheter Aortic Valve Replacement 17.04.2024 2:50 ↓

Commentary by Dr Yat-Yin Lam

JACC: Asia Pulse - Social Determinants of Health and Cardiovascular Risk Among Asian Subgroups 16.04.2024 15:45 ↓

Drs. Eugene Yang and Amber Tang discuss social determinants and impact on cardiovascular risk factors among disaggregated Asian subgroups.

JACC: CardioOncology Pulse - The PROACT Trial: Findings and Key Takeaways 16.04.2024 16:26 ↓

JACC: CardioOncology Editor-in-chief, Bonnie Ky, MD, MSCE, FACC and David Austin, MD, FRCP discuss PROACT, a phase three randomized open label blinded endpoint superiority trial of enalapril to prevent anthracycline induced cardiotoxicity.

JACC: CardioOncology - Effect of Tafamidis on Renal Function in Patients With Transthyretin Amyloid Cardiomyopathy in ATTR-ACT 16.04.2024 2:48 ↓

Commentary by Bonnie Ky

JACC: CardioOncology - Arterial Thromboembolism in Japanese Cancer Patients: Incidence, Predictors, and Survival Impact 16.04.2024 2:51 ↓

Commentary by Yugo Yamashita

JACC: CardioOncology - Cardiovascular Eligibility Criteria and Adverse Event Reporting in Combined Immune Checkpoint and VEGF Inhibitors Trials 16.04.2024 2:46 ↓

Commentary by Corralea Kappel

JACC: CardioOncology - Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation in Patients with Chronic Lymphocytic Leukemia 16.04.2024 2:15 ↓

Commentary by Saro Armenian

JACC: CardioOncology - A Biomarker-Based Diagnostic Model for Cardiac Dysfunction in Childhood Cancer Survivors 16.04.2024 3:39 ↓

Commentary by Saro Armenian

JACC: CardioOncology - Anthracycline Cardiotoxicity Induces Progressive Changes in Myocardial Metabolism and Mitochondrial Quality Control: Novel Therapeutic Target 16.04.2024 3:11 ↓

Commentary by Brian Jensen

JACC: CardioOncology - Impact of Preexisting Heart Failure on Treatment and Outcomes in Older Patients with Hodgkin Lymphoma 16.04.2024 3:37 ↓

Commentary by Gabriel Aleixo

JACC: CardioOncology - April 2024 Issue Summary 16.04.2024 23:12 ↓

Audio Summary of the March Issue with Introduction by Dr. Bonnie Ky.

JACC: Asia - April 1, 2024 Issue Summary 09.04.2024 15:06 ↓

Audio Summary of the April 1, 2024 Issue by Dr. Jian'an Wang

JACC: Cardiovascular Interventions - Angiographic Coronary Slow Flow Is Not A Valid Surrogate for Invasively Diagnosed Coronary Microvascular Dysfunction 08.04.2024 20:00 ↓

Commentary by Dr. Abdullah Al-Abcha and Dr. John Blair